Nutromics receives FDA Breakthrough Device Designation
Nutromics is building a wearable lab-on-a-patch™ for continuous molecular monitoring. Today the company has announced that the FDA has granted Breakthrough Device Designation (BDD) for its first product in development - a wearable for vancomycin therapeutic drug monitoring.
